Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$31.36 - $39.99 $1.31 Million - $1.67 Million
41,704 New
41,704 $1.34 Million
Q3 2023

Nov 08, 2023

BUY
$21.23 - $24.28 $273,251 - $312,507
12,871 New
12,871 $287,000
Q1 2023

May 11, 2023

BUY
$23.0 - $29.88 $1.32 Million - $1.72 Million
57,544 Added 543.18%
68,138 $1.63 Million
Q4 2022

Feb 14, 2023

SELL
$16.14 - $23.55 $13,896 - $20,276
-861 Reduced 7.52%
10,594 $245,000
Q3 2022

Nov 14, 2022

BUY
$15.46 - $20.1 $177,094 - $230,245
11,455 New
11,455 $184,000
Q2 2022

Aug 09, 2022

SELL
$14.22 - $20.88 $735,927 - $1.08 Million
-51,753 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$17.2 - $22.5 $718,151 - $939,442
41,753 Added 417.53%
51,753 $1.05 Million
Q4 2021

Feb 10, 2022

BUY
$17.5 - $21.35 $175,000 - $213,500
10,000 New
10,000 $187,000
Q3 2020

Oct 15, 2020

SELL
$15.78 - $20.82 $187,071 - $246,821
-11,855 Closed
0 $0
Q2 2020

Jul 29, 2020

BUY
$15.49 - $23.51 $183,633 - $278,711
11,855 New
11,855 $207,000
Q1 2020

Apr 29, 2020

SELL
$13.89 - $25.45 $164,943 - $302,218
-11,875 Closed
0 $0
Q4 2019

Jan 23, 2020

BUY
$10.7 - $22.24 $18,874 - $39,231
1,764 Added 17.45%
11,875 $244,000
Q3 2019

Oct 16, 2019

BUY
$10.16 - $13.28 $102,727 - $134,274
10,111 New
10,111 $116,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.12B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.